Journal of Clinical Imaging Science
Acute pulmonary embolism (PE) is a significant cause of mortality and morbidity across the globe. Over the last few decades, there have been major therapeutic advances in acute PE management, including catheter-based therapy. However, the effectiveness of catheter-based therapy in acute PE is not supported by Level I evidence, making the use of thi...
Lung India : Official Organ of Indian Chest Society
Background: Mechanical thrombectomy plays an important role in the management of acute pulmonary embolism (PE), either when rapid clot dissolution is needed or when thrombolytics are contraindicated. We describe our clinical and technical experience with the FlowTriever mechanical thrombectomy device in patients with acute PE. Materials and Methods...
The Journal of emergency medicine
The FlowTriever Pulmonary Embolectomy Clinical Study (FLARE) was a multicenter, single-arm trial that demonstrated effectiveness of the FlowTriever percutaneous pulmonary embolectomy system in reducing right ventricular/left ventricular (RV/LV) diameter ratio in patients with acute intermediate-risk pulmonary embolism (PE). Patients diagnosed in em...
EJVES Short Reports
• FlowTriever system is recently cleared by FDA for mechanical thrombectomy of pulmonary embolism. • This is the first case of mechanical thrombectomy in the right atrium or ventricle under echocardiography guidance. • The mechanical thrombectomy in the right atrium/ventricle was safe and resolved the patient's symptoms.